Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

IDYAIDEAYA Biosciences, Inc.

Nasdaq · CIK 0001676725
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts231

Identity from submissions API

NameIDEAYA Biosciences, Inc.
CIK0001676725
TickersIDYA
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN474268251
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone650-443-6209
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
5000 SHORELINE CT, SUITE 300
SOUTH SAN FRANCISCO
CA
94080
CA
Mailing address
5000 SHORELINE CT, SUITE 300
SOUTH SAN FRANCISCO
CA
94080
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

506 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-03 S-8 S-8 0001193125-26-445449 333-299793 261518023 33 399023 1 1
2026-11-03 10-Q 10-Q 0001193125-26-445294 001-38915 261517176 34 10262655 1 1
2026-11-03 8-K 8-K 2.02,9.01 0001193125-26-444225 001-38915 261514211 34 365718 1 1
2026-10-08 4 FORM 4 0001610717-26-000434 11132
2026-10-06 144 xsl144X01/primary_doc.xml 0001968582-26-001043 001-38915 261444165 33 5054
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-097056 005-91018 261280915 34 19787
2026-08-04 10-Q 10-Q 0001193125-26-332774 001-38915 261238551 34 9924999 1 1
2026-08-04 8-K 8-K 2.02,9.01 0001193125-26-331381 001-38915 261235248 34 355757 1 1
2026-07-31 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-001376 005-91018 261225997 34 7548
2026-07-09 4 FORM 4 0001610717-26-000336 8998
2026-07-07 144 xsl144X01/primary_doc.xml 0001968582-26-000707 001-38915 261159920 33 4948
2026-06-23 8-K 8-K 5.07,8.01 0001193125-26-279427 001-38915 261111041 34 147533 1 1
2026-06-18 4 xslF345X06/form4.xml 0001610717-26-000265 5322
2026-06-18 4 xslF345X06/form4.xml 0001610717-26-000264 5434
2026-06-18 4 xslF345X06/form4.xml 0001610717-26-000263 5450
2026-06-18 4 xslF345X06/form4.xml 0001610717-26-000261 5500
2026-06-18 4 xslF345X06/form4.xml 0001610717-26-000260 5440
2026-06-18 4 xslF345X06/form4.xml 0001610717-26-000259 5445
2026-06-10 8-K 8-K 8.01,9.01 0001193125-26-265833 001-38915 261079758 34 653308 1 1
2026-06-09 424B5 424B5 0001193125-26-264032 333-295560 261077142 33 778920
2026-06-08 424B5 424B5 0001193125-26-261756 333-295560 261072791 33 621800
2026-06-05 3 xslF345X06/form3.xml 0001610717-26-000184 12147
2026-06-03 8-K 8-K 8.01 0001193125-26-254476 001-38915 261058787 34 142811 1 1
2026-06-01 8-K 8-K 7.01,8.01,9.01 0001193125-26-251399 001-38915 261050690 34 3183769 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000141 005-91018 26984905 34 12229
2026-05-05 8-K 8-K 8.01,9.01 0001193125-26-206806 001-38915 26944699 34 167812 1 1
2026-05-05 424B5 424B5 0001193125-26-206788 333-295560 26944672 33 734781 1 1
2026-05-05 S-3ASR S-3ASR 0001193125-26-206523 333-295560 26943700 33 810830 1 1
2026-05-05 10-Q 10-Q 0001193125-26-206357 001-38915 26942971 34 10586384 1 1
2026-05-05 8-K 8-K 2.02,9.01 0001193125-26-204944 001-38915 26940200 34 305412 1 1
2026-04-30 DEFA14A DEFA14A 0001193125-26-197185 001-38915 26925037 34 476742
2026-04-29 DEF 14A DEF 14A 0001193125-26-191501 001-38915 26915837 34 10704748 1 1
2026-04-29 ARS ARS 0001193125-26-191489 001-38915 26915776 34 1852542
2026-04-13 8-K 8-K 8.01 0001193125-26-151893 001-38915 26856354 34 144382 1 1
2026-04-09 8-K 8-K 8.01 0001193125-26-148777 001-38915 26849709 34 140677 1 1
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001612 005-91018 26801746 34 7288
2026-03-02 4 xslF345X05/form4.xml 0001610717-26-000078 6239
2026-02-17 S-8 S-8 0001193125-26-054973 333-293525 26643096 33 459719 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-001132 005-91018 26642064 34 12240
2026-02-17 10-K 10-K 0001193125-26-054533 001-38915 26640652 34 17977252 1 1
2026-02-17 8-K 8-K 2.02,9.01 0001193125-26-052741 001-38915 26635877 34 344732 1 1
2026-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001422848-26-000019 005-91018 26624040 34 7664
2026-02-02 4 xslF345X05/form4.xml 0001610717-26-000038 5438
2026-02-02 4 xslF345X05/form4.xml 0001610717-26-000037 5496
2026-02-02 4 xslF345X05/form4.xml 0001610717-26-000036 5446
2026-02-02 4 xslF345X05/form4.xml 0001610717-26-000035 5472
2026-02-02 4 xslF345X05/form4.xml 0001610717-26-000034 5472
2026-02-02 4 xslF345X05/form4.xml 0001610717-26-000033 8548
2026-02-02 4 xslF345X05/form4.xml 0001610717-26-000032 8592
2026-01-12 8-K 8-K 8.01 0001193125-26-009653 001-38915 26524559 34 153907 1 1
2026-01-12 8-K 8-K 7.01,9.01 0001193125-26-009641 001-38915 26524539 34 4435847 1 1
2026-01-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001623632-26-000034 005-91018 26517497 34 47194
2025-12-12 8-K 8-K 1.02 0001193125-25-317541 001-38915 251568084 34 140475 1 1
2025-12-05 8-K 8-K 8.01 0001193125-25-309716 001-38915 251553212 34 138372 1 1
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000301 005-91018 251483611 34 9649
2025-11-04 10-Q 10-Q 0001193125-25-264632 001-38915 251448874 34 10736972 1 1
2025-11-04 8-K 8-K 2.02,9.01 0001193125-25-263383 001-38915 251446216 34 379102 1 1
2025-10-20 8-K 8-K 8.01 0001193125-25-243558 001-38915 251403838 34 163595 1 1
2025-09-08 8-K 8-K 8.01 0001193125-25-197605 001-38915 251298445 34 180666 1 1
2025-09-02 8-K 8-K 1.01 0001193125-25-193238 001-38915 251282778 34 141090 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000231 005-91018 251215888 34 9649
2025-08-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001422848-25-000172 005-91018 251209771 34 7544
2025-08-05 S-8 S-8 0000950170-25-103078 333-289256 251185275 33 426445 1 1
2025-08-05 10-Q 10-Q 0000950170-25-102967 001-38915 251184719 34 9290652 1 1
2025-08-05 8-K 8-K 2.02,9.01 0000950170-25-102353 001-38915 251182614 34 338081 1 1
2025-06-27 3 xslF345X02/form3.xml 0001610717-25-000266 11983
2025-06-27 8-K 8-K 5.02 0001193125-25-151257 001-38915 251086298 34 134236 1 1
2025-06-26 4 xslF345X05/form4.xml 0001610717-25-000265 5185
2025-06-26 4 xslF345X05/form4.xml 0001610717-25-000264 5297
2025-06-26 4 xslF345X05/form4.xml 0001610717-25-000263 5308
2025-06-26 4 xslF345X05/form4.xml 0001610717-25-000262 5363
2025-06-26 4 xslF345X05/form4.xml 0001610717-25-000261 5303
2025-06-26 4 xslF345X05/form4.xml 0001610717-25-000260 5313
2025-06-24 8-K 8-K 5.07 0001193125-25-145830 001-38915 251070232 34 145509 1 1
2025-06-09 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-002684 005-91018 251034179 34 19170
2025-05-20 ARS ARS 0000950170-25-075149 001-38915 25968577 34 4714180
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000151 005-91018 25943936 34 9648
2025-05-06 10-Q 10-Q 0000950170-25-064438 001-38915 25917203 34 9628972 1 1
2025-05-06 8-K 8-K 2.02,9.01 0000950170-25-063938 001-38915 25915104 34 326089 1 1
2025-04-30 DEF 14A DEF 14A 0000950170-25-060530 001-38915 25890663 34 4917499 1 1
2025-04-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001576419-25-000610 005-91018 25844547 34 11120
2025-04-02 8-K 8-K 5.02 0001193125-25-071309 001-38915 25804199 34 144099 1 1
2025-02-28 4 xslF345X05/form4.xml 0001610717-25-000043 5456
2025-02-28 4 xslF345X05/form4.xml 0001610717-25-000042 5479
2025-02-28 4 xslF345X05/form4.xml 0001610717-25-000041 5514
2025-02-28 4 xslF345X05/form4.xml 0001610717-25-000040 5506
2025-02-28 4 xslF345X05/form4.xml 0001610717-25-000039 5442
2025-02-28 4 xslF345X05/form4.xml 0001610717-25-000038 5482
2025-02-19 4 xslF345X05/form4.xml 0001610717-25-000021 6605
2025-02-18 S-8 S-8 0000950170-25-022361 333-285028 25635625 33 676777 1 1
2025-02-18 10-K 10-K 0000950170-25-022183 001-38915 25634732 34 17140249 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000078 005-91018 25625659 34 9662
2025-02-13 8-K 8-K 2.02,9.01 0000950170-25-019314 001-38915 25616975 34 378435 1 1
2025-02-10 8-K 8-K 5.02 0001193125-25-023076 001-38915 25603515 34 145701 1 1
2025-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-001211 005-91018 25592208 34 12169
2024-12-30 8-K 8-K 1.01,9.01 0001193125-24-286169 001-38915 241586858 34 169325 1 1
2024-12-20 3 xslF345X02/form3.xml 0001610717-24-000549 11984
2024-11-14 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0000921895-24-002713 005-91018 241462840 34 276775
2024-11-14 SC 13G/A JANUS AMENDMENT 0001274173-24-000136 005-91018 241460830 34 10613
2024-11-14 SC 13G/A idya13gasep24.txt 0000080255-24-001448 005-91018 34 6795
2024-11-12 SC 13G/A filing.txt 0000315066-24-002839 005-91018 241444881 34 8378
2024-11-04 10-Q 10-Q 0000950170-24-120675 001-38915 241423450 34 8371545 1 1
2024-11-04 8-K 8-K 2.02,9.01 0000950170-24-120257 001-38915 241420555 34 371580 1 1
2024-10-25 8-K 8-K 8.01 0001193125-24-243413 001-38915 241393974 34 159312 1 1
2024-10-04 8-K 8-K 8.01,9.01 0001193125-24-233038 001-38915 241354871 34 163141 1 1
2024-09-27 4 xslF345X05/form4.xml 0001610717-24-000497 5448
2024-09-27 3 xslF345X02/form3.xml 0001610717-24-000496 10478
2024-09-23 8-K 8-K 8.01 0001193125-24-223230 001-38915 241314564 34 154169 1 1
2024-08-26 144 xsl144X01/primary_doc.xml 0001968582-24-000746 001-38915 241242345 33 4627
2024-08-06 S-8 S-8 0001193125-24-194956 333-281301 241180392 33 257149 1 1
2024-08-06 10-Q 10-Q 0000950170-24-091823 001-38915 241179401 34 7254787 1 1
2024-08-06 10-Q/A 10-Q/A 0001193125-24-194852 001-38915 241178980 34 354155 1 1
2024-08-06 8-K 8-K 2.02,9.01 0000950170-24-091175 001-38915 241176899 34 356852 1 1
2024-07-31 8-K 8-K 1.01,9.01 0000950170-24-088200 001-38915 241159697 34 219763 1 1
2024-07-11 8-K 8-K 8.01,9.01 0001193125-24-177726 001-38915 241112183 34 622387 1 1
2024-07-10 424B5 424B5 0001193125-24-177309 333-272936 241110582 33 625353
2024-07-09 424B5 424B5 0001193125-24-176798 333-272936 241108052 33 597727
2024-07-09 8-K 8-K 2.02,8.01 0001193125-24-176736 001-38915 241107574 34 146625 1 1
2024-07-08 8-K 8-K 8.01 0001193125-24-175867 001-38915 241103283 34 155595 1 1
2024-06-27 4 xslF345X05/form4.xml 0001610717-24-000367 10317
2024-06-27 8-K 8-K 5.02 0001193125-24-169573 001-38915 241075197 34 142992 1 1
2024-06-03 8-K 8-K 8.01 0000950170-24-067644 001-38915 241011886 34 169121 1 1
2024-05-31 8-K 8-K 5.07 0000950170-24-067407 001-38915 241010568 34 188010 1 1
2024-05-31 4 xslF345X05/form4.xml 0001610717-24-000279 12820
2024-05-31 4 xslF345X05/form4.xml 0001610717-24-000278 12842
2024-05-31 4 xslF345X05/form4.xml 0001610717-24-000277 12831
2024-05-31 4 xslF345X05/form4.xml 0001610717-24-000276 12802
2024-05-31 4 xslF345X05/form4.xml 0001610717-24-000275 12875
2024-05-31 4 xslF345X05/form4.xml 0001610717-24-000274 12692
2024-05-31 4 xslF345X05/form4.xml 0001610717-24-000273 12819
2024-05-31 4 xslF345X05/form4.xml 0001610717-24-000272 10980
2024-05-29 144 xsl144X01/primary_doc.xml 0001968582-24-000434 001-38915 24999444 33 4750
2024-05-16 4 xslF345X05/form4.xml 0001610717-24-000239 27156
2024-05-14 144 xsl144X01/primary_doc.xml 0001968582-24-000373 001-38915 24944594 33 4704
2024-05-07 10-Q 10-Q 0000950170-24-054466 001-38915 24921766 34 7110327 1 1
2024-05-07 8-K 8-K 2.02,9.01 0000950170-24-053900 001-38915 24919438 34 290166 1 1
2024-04-24 ARS ARS 0000950170-24-047550 001-38915 24870469 34 1807064
2024-04-19 DEF 14A DEF 14A 0000950170-24-045724 001-38915 24855839 34 6204248 1 1
2024-03-12 8-K 8-K 1.01 0000950170-24-029619 001-38915 24740112 34 185038 1 1
2024-03-04 4 xslF345X05/form4.xml 0001610717-24-000120 5481
2024-03-04 4 xslF345X05/form4.xml 0001610717-24-000119 5558
2024-03-04 4 xslF345X05/form4.xml 0001610717-24-000118 5455
2024-03-04 4 xslF345X05/form4.xml 0001610717-24-000117 5505
2024-03-04 4 xslF345X05/form4.xml 0001610717-24-000116 5510
2024-02-20 S-8 S-8 0000950170-24-017149 333-277189 24653983 33 370922
2024-02-20 10-K 10-K 0000950170-24-017093 001-38915 24653238 34 13932324 1 1
2024-02-20 8-K 8-K 2.02,9.01 0000950170-24-016758 001-38915 24650519 34 342358 1 1
2024-02-14 SC 13G JHG PLC OWNS >5% 0001274173-24-000059 005-91018 24635360 34 10612
2024-02-14 SC 13G idya13gdec23.txt 0000080255-24-000744 005-91018 34 6602
2024-02-14 SC 13G/A AMENDMENT NO. 1 TO SCHEDULE 13G 0000921895-24-000446 005-91018 24633295 34 280528
2024-02-14 SC 13G/A d10980371_13g-a.htm 0000919574-24-001237 005-91018 24632113 34 163601
2024-02-13 SC 13G/A idya13ga.htm 0000935836-24-000153 005-91018 24631154 34 60703
2024-02-13 SC 13G SCHEDULE 13G 0001104659-24-021164 005-91018 24628637 34 13148
2024-02-13 4 xslF345X05/form4.xml 0001610717-24-000059 5276
2024-02-12 4 xslF345X05/form4.xml 0001610717-24-000053 14039
2024-02-12 SC 13G filing.txt 0000315066-24-001626 005-91018 24618413 34 8292
2024-02-09 144 xsl144X01/primary_doc.xml 0001968582-24-000102 001-38915 24616543 33 8780
2024-02-07 SC 13G/A IDEAYA BIOSCIENCES, INC. 0000902664-24-001184 005-91018 24602215 34 100515
2024-02-05 4 xslF345X05/form4.xml 0001610717-24-000043 9562
2024-02-01 SC 13G/A SC 13G/A 0001193125-24-021891 005-91018 24587437 34 68161
2024-02-01 144 xsl144X01/primary_doc.xml 0001968582-24-000070 001-38915 24587069 33 6592
2024-01-25 SC 13G/A us45166a1025_012524.txt 0001086364-24-003305 005-91018 24561090 34 13751
2024-01-24 4 xslF345X05/form4.xml 0001610717-24-000041 5276
2024-01-23 8-K 8-K 8.01 0000950170-24-006249 001-38915 24550420 34 159332 1 1
2024-01-19 8-K 8-K 1.01,9.01 0001193125-24-011346 001-38915 24546462 34 458800 1 1
2024-01-19 424B5 424B5 0001193125-24-011343 333-272936 24546449 33 477580
2024-01-18 SC 13G/A idya1570-form.htm 0001623632-24-000040 005-91018 24540408 34 433615
2024-01-17 4 xslF345X05/form4.xml 0001610717-24-000029 5276
2024-01-17 4 xslF345X05/form4.xml 0001610717-24-000028 14040
2024-01-16 8-K 8-K 8.01 0000950170-24-004395 001-38915 24533527 34 155793 1 1
2024-01-12 144 xsl144X01/primary_doc.xml 0001968582-24-000034 001-38915 24532330 33 5243
2024-01-12 144 xsl144X01/primary_doc.xml 0001968582-24-000032 001-38915 24532275 33 5325
2024-01-12 8-K 8-K 8.01 0001193125-24-007021 001-38915 24530513 34 143702 1 1
2023-12-27 144 xsl144X01/primary_doc.xml 0001968582-23-000858 001-38915 231518270 33 11742
2023-12-19 4 xslF345X05/form4.xml 0001610717-23-000406 12435
2023-12-19 4 xslF345X05/form4.xml 0001610717-23-000405 8720
2023-12-18 4 xslF345X05/form4.xml 0001610717-23-000403 6130
2023-12-15 144 xsl144X01/primary_doc.xml 0001968582-23-000803 001-38915 231491929 33 4467
2023-12-15 144 xsl144X01/primary_doc.xml 0001968582-23-000801 001-38915 231491878 33 5142
2023-12-14 144 xsl144X01/primary_doc.xml 0001968582-23-000789 001-38915 231488478 33 4524
2023-12-11 144 xsl144X01/primary_doc.xml 0001968582-23-000752 001-38915 231479470 33 8908
2023-12-04 144 xsl144X01/primary_doc.xml 0001968582-23-000742 001-38915 231464132 33 5686
2023-12-04 8-K 8-K 1.01,9.01 0000950170-23-067461 001-38915 231461204 34 189117 1 1
2023-11-28 144 xsl144X01/primary_doc.xml 0001968582-23-000718 001-38915 231447761 33 5039
2023-11-27 144 xsl144X01/primary_doc.xml 0001968582-23-000706 001-38915 231441106 33 4393
2023-11-17 8-K 8-K 1.01 0000950170-23-064639 001-38915 231416345 34 165184 1 1
2023-11-07 4 xslF345X05/form4.xml 0001610717-23-000322 8875
2023-11-07 10-Q 10-Q 0000950170-23-060206 001-38915 231383549 34 9407434 1 1
2023-11-07 8-K 8-K 2.02,9.01 0000950170-23-059717 001-38915 231381356 34 411749 1 1
2023-10-27 8-K 8-K 8.01,9.01 0001193125-23-265158 001-38915 231355872 34 646790 1 1
2023-10-26 424B5 424B5 0001193125-23-263354 333-272936 231347296 33 677846
2023-10-24 424B5 424B5 0001193125-23-261771 333-272936 231343475 33 650728
2023-10-24 8-K 8-K 2.02,8.01 0001193125-23-261688 001-38915 231342921 34 151216 1 1
2023-10-23 8-K 8-K 8.01 0001193125-23-260370 001-38915 231338561 34 173526 1 1
2023-09-26 8-K 8-K 5.02 0001193125-23-241785 001-38915 231277100 34 148835 1 1
2023-09-14 4 xslF345X05/form4.xml 0001610717-23-000279 9725
2023-09-06 4 xslF345X05/form4.xml 0001610717-23-000258 14187
2023-09-06 4 xslF345X05/form4.xml 0001610717-23-000257 5194
2023-09-01 144 xsl144X01/primary_doc.xml 0001968582-23-000466 001-38915 231233623 33 5889
2023-08-31 4 xslF345X05/form4.xml 0001610717-23-000251 5111
2023-08-23 4 xslF345X05/form4.xml 0001610717-23-000234 5113
2023-08-18 4 xslF345X05/form4.xml 0001610717-23-000233 7914
2023-08-11 4 xslF345X05/form4.xml 0001610717-23-000226 8873
2023-08-11 4 xslF345X05/form4.xml 0001610717-23-000225 5115
2023-08-10 10-Q 10-Q 0000950170-23-041394 001-38915 231159995 34 17627952 1 1
2023-08-10 8-K 8-K 2.02,9.01 0000950170-23-040894 001-38915 231157028 34 449144 1 1
2023-08-09 144 xsl144X01/primary_doc.xml 0001968582-23-000387 001-38915 231155880 33 5028
2023-07-12 4 xslF345X04/form4.xml 0001610717-23-000204 12639
2023-07-10 144 xsl144X01/primary_doc.xml 0001968582-23-000316 001-38915 231080191 33 6412
2023-07-03 3 FORM 3 0001567619-23-006501 16937
2023-07-03 8-K 8-K 5.02 0001193125-23-181337 001-38915 231065275 34 150312 1 1
2023-06-30 8-K 8-K 1.01,9.01 0001193125-23-180373 001-38915 231061590 34 450563 1 1
2023-06-26 424B5 424B5 0001193125-23-175273 333-272936 231043361 33 484325
2023-06-26 S-3ASR S-3ASR 0001193125-23-175161 333-272936 231042691 33 710998
2023-06-09 4 xslF345X04/form4.xml 0001610717-23-000116 5225
2023-06-09 4 xslF345X04/form4.xml 0001610717-23-000115 5231
2023-06-09 4 xslF345X04/form4.xml 0001610717-23-000114 5256
2023-06-09 4 xslF345X04/form4.xml 0001610717-23-000113 5226
2023-06-09 4 xslF345X04/form4.xml 0001610717-23-000112 5286
2023-06-09 4 xslF345X04/form4.xml 0001610717-23-000111 5236
2023-06-09 4 xslF345X04/form4.xml 0001610717-23-000110 5220
2023-06-09 4 xslF345X04/form4.xml 0001610717-23-000109 5108
2023-06-09 8-K 8-K 5.07,8.01 0000950170-23-027259 001-38915 231005284 34 215863 1 1
2023-06-06 8-K 8-K 1.01 0000950170-23-026512 001-38915 23994784 34 180894 1 1
2023-06-02 4 xslF345X04/form4.xml 0001610717-23-000087 13634
2023-05-24 4 xslF345X04/form4.xml 0001610717-23-000063 8320
2023-05-22 144 xsl144X01/primary_doc.xml 0001968582-23-000138 001-38915 23945099 33 4343
2023-05-16 8-K 8-K 1.01,1.02,9.01 0000950170-23-022333 001-38915 23925459 34 232995 1 1
2023-05-15 ARS ARS 0000950170-23-021892 001-38915 23917859 34 1182373
2023-05-09 10-Q 10-Q 0000950170-23-019605 001-38915 23901807 34 8587172 1 1
2023-05-09 8-K 8-K 2.02,9.01 0000950170-23-019083 001-38915 23899757 34 406343 1 1
2023-04-27 8-K 8-K 8.01,9.01 0001193125-23-122115 001-38915 23856802 34 621240 1 1
2023-04-26 424B5 424B5 0001193125-23-115873 333-254606 23846426 33 667781
2023-04-24 424B5 424B5 0001193125-23-113017 333-254606 23840714 33 642533
2023-04-24 8-K 8-K 2.02,8.01 0001193125-23-112888 001-38915 23840294 34 150091 1 1
2023-04-24 8-K 8-K 8.01 0001193125-23-111671 001-38915 23837849 34 179409 1 1
2023-04-14 4 xslF345X04/form4.xml 0001610717-23-000009 6730
2023-04-14 DEF 14A DEF 14A 0000950170-23-012806 001-38915 23819896 34 2079253
2023-04-13 4 xslF345X04/form4.xml 0001610717-23-000007 6520
2023-03-24 SC 13G SCHEDULE 13G 0000921895-23-000758 005-91018 23760329 34 285290
2023-03-13 8-K 8-K 8.01 0001193125-23-067903 001-38915 23725335 34 147970 1 1
2023-03-07 S-8 S-8 0001193125-23-063052 333-270334 23713361 33 282805
2023-03-07 10-K 10-K 0000950170-23-006456 001-38915 23712530 34 13180263 1 1
2023-03-07 8-K 8-K 2.02,9.01 0000950170-23-006349 001-38915 23710934 34 452785 1 1
2023-02-28 4 FORM 4 0001567619-23-003950 5724
2023-02-28 4 FORM 4 0001567619-23-003948 5668
2023-02-28 4 FORM 4 0001567619-23-003947 5699
2023-02-28 4 FORM 4 0001567619-23-003945 5654
2023-02-28 4 FORM 4 0001567619-23-003944 5661
2023-02-27 SC 13G IDEAYA BIOSCIENCES, INC. 0000902664-23-002034 005-91018 23675425 34 107679
2023-02-14 SC 13G/A SCHEDULE 13G/A, AMENDMENT #1 0000899140-23-000396 005-91018 23629698 34 60216
2023-02-14 SC 13G/A ideaya13ga1.htm 0000935836-23-000257 005-91018 23629460 34 63168
2023-02-14 SC 13G/A d9176193_13g-a.htm 0000919574-23-001630 005-91018 23628094 34 164872
2023-02-14 SC 13G/A ff0001742117_13ga-ideaya.htm 0000895345-23-000139 005-91018 23626193 34 107909
2023-02-14 SC 13G/A idya13gadec22.txt 0000080255-23-002702 005-91018 34 7168
2023-02-14 SC 13G/A AMENDMENT NO. 1 TO THE SCHEDULE 13G 0000921895-23-000540 005-91018 23625270 34 276971
2023-02-14 SC 13G/A IDEAYA BIOSCIENCES, INC. 0000902664-23-001731 005-91018 23623881 34 62567
2023-02-09 SC 13G/A IDEAYA BIOSCIENCES, INC. 0000902664-23-001351 005-91018 23604693 34 105077
2023-02-01 SC 13G/A form822.htm 0001623632-23-000220 005-91018 23575309 34 212992
2023-01-31 SC 13G/A us45166a1025_013123.txt 0001306550-23-005126 005-91018 23571775 34 13414
2022-12-14 3 FORM 3 0001567619-22-021570 13132
2022-11-08 10-Q 10-Q 0000950170-22-023207 001-38915 221368932 34 10814439 1 1
2022-11-08 8-K 8-K 2.02,9.01 0000950170-22-022837 001-38915 221367056 34 454498 1 1
2022-10-27 SC 13G IDEAYA BIOSCIENCES, INC. 0000902664-22-004659 005-91018 221337695 34 106498
2022-09-19 8-K 8-K 8.01,9.01 0001193125-22-247108 001-38915 221250808 34 445963 1 1
2022-09-15 424B5 424B5 0001193125-22-245697 333-254606 221246377 33 812042
2022-09-14 424B5 424B5 0001193125-22-244824 333-254606 221243590 33 812430
2022-09-14 8-K 8-K 8.01 0001193125-22-244793 001-38915 221243481 34 171643 1 1
2022-08-15 10-Q 10-Q 0000950170-22-017204 001-38915 221162202 34 9456245 1 1
2022-08-15 8-K 8-K 2.02,9.01 0000950170-22-017203 001-38915 221162200 34 407617 1 1
2022-07-27 8-K 8-K 1.01,9.01 0001193125-22-202576 001-38915 221108749 34 166349 1 1
2022-06-10 4 FORM 4 0001567619-22-012703 5450
2022-06-10 4 FORM 4 0001567619-22-012702 5579
2022-06-10 4 FORM 4 0001567619-22-012700 5578
2022-06-10 4 FORM 4 0001567619-22-012699 5598
2022-06-10 4 FORM 4 0001567619-22-012698 5598
2022-06-10 4 FORM 4 0001567619-22-012697 5625
2022-06-10 4 FORM 4 0001567619-22-012696 5562
2022-06-10 4 FORM 4 0001567619-22-012694 5573
2022-06-10 8-K 8-K 5.07 0000950170-22-011482 001-38915 221008984 34 197874 1 1
2022-05-10 10-Q 10-Q 0000950170-22-008946 001-38915 22909451 34 9348703 1 1
2022-05-10 8-K 8-K 2.02,9.01 0000950170-22-008681 001-38915 22907197 34 337003 1 1
2022-05-02 SC 13G SCHEDULE 13G 0001193805-22-000728 005-91018 22882929 34 294607
2022-04-26 DEF 14A DEF 14A 0001564590-22-015756 001-38915 22855515 34 2088501
2022-04-14 4 FORM 4 0001567619-22-008545 4796
2022-04-06 4 FORM 4 0001567619-22-008194 5566
2022-04-06 3 FORM 3 0001567619-22-008190 10758
2022-04-06 8-K 8-K 5.02,9.01 0000950170-22-005384 001-38915 22809307 34 195255 1 1
2022-03-18 SC 13G ideaya13g2.htm 0000935836-22-000253 005-91018 22753301 34 59100
2022-03-18 10-K 10-K 0001564590-22-010922 001-38915 22750033 34 11945564 1 1
2022-03-17 S-8 S-8 0001564590-22-010903 333-263657 22749659 33 225898
2022-03-15 8-K 8-K 2.02,9.01 0001564590-22-010202 001-38915 22738857 34 414102 1 1
2022-03-02 4 FORM 4 0001567619-22-006126 5701
2022-03-02 4 FORM 4 0001567619-22-006125 5726
2022-03-02 4 FORM 4 0001567619-22-006124 5661
2022-03-02 4 FORM 4 0001567619-22-006123 5652
2022-02-18 SC 13G SCHEDULE 13G 0000899140-22-000360 005-91018 22653889 34 70006
2022-02-14 SC 13G idya13gdec21.txt 0000080255-22-002212 005-91018 34 6934
2022-02-14 SC 13G form43.htm 0001623632-22-000238 005-91018 22628995 34 279684
2022-02-14 SC 13G/A d9176193_13g-a.htm 0000919574-22-001269 005-91018 22626089 34 165483
2022-02-14 SC 13G/A IDEAYA BIOSCIENCES, INC. 0000902664-22-001596 005-91018 22625707 34 62873
2022-02-14 SC 13G/A AMENDMENT NO. 5 TO THE SCHEDULE 13G 0000921895-22-000447 005-91018 22624024 34 276842
2022-02-04 SC 13G us45166a1025_020422.txt 0000834237-22-007332 005-91018 22593601 34 13410
2021-12-01 SC 13G d9072682.htm 0000919574-21-007291 005-91018 211461798 34 164435
2021-11-15 10-Q 10-Q 0001564590-21-056989 001-38915 211410107 34 9299193 1 1
2021-11-15 8-K 8-K 2.02,9.01 0001564590-21-056781 001-38915 211406003 34 390357 1 1
2021-10-27 4 FORM 4 0001567619-21-018800 5731
2021-10-27 3 FORM 3 0001567619-21-018799 11141
2021-10-07 4 FORM 4 0001567619-21-018029 11287
2021-09-09 4 FORM 4 0001567619-21-016927 20105
2021-09-09 4 FORM 4 0001567619-21-016924 5384
2021-09-07 4 FORM 4 0001567619-21-016820 5399
2021-08-11 4 FORM 4 0001567619-21-015084 11286
2021-08-11 SC 13D/A SC 13D/A 0001104659-21-103502 005-91018 211163868 34 220871
2021-08-10 10-Q 10-Q 0001564590-21-043062 001-38915 211159805 34 8829904 1 1
2021-08-10 8-K 8-K 2.02,9.01 0001564590-21-042849 001-38915 211158312 34 247045
2021-07-29 4 FORM 4 0001567619-21-014178 13162
2021-07-29 4 FORM 4 0001567619-21-014176 9219
2021-07-12 8-K 8-K 8.01,9.01 0001193125-21-213023 001-38915 211085560 34 243811
2021-07-08 4 FORM 4 0001567619-21-013156 10738
2021-07-08 4 FORM 4 0001567619-21-013155 18092
2021-07-08 424B5 424B5 0001193125-21-210771 333-254606 211080212 33 771931
2021-07-06 424B5 424B5 0001193125-21-208716 333-254606 211074082 33 775612
2021-06-28 8-K 8-K 8.01 0001193125-21-200992 001-38915 211049860 34 28168
2021-06-17 4 FORM 4 0001567619-21-012384 14765
2021-06-16 4 FORM 4 0001567619-21-012238 5579
2021-06-16 4 FORM 4 0001567619-21-012208 5450
2021-06-16 4 FORM 4 0001567619-21-012207 5562
2021-06-16 4 FORM 4 0001567619-21-012206 5578
2021-06-16 4 FORM 4 0001567619-21-012205 5628
2021-06-16 4 FORM 4 0001567619-21-012204 5573
2021-06-14 8-K 8-K 5.07 0001564590-21-032771 001-38915 211014544 34 44494
2021-06-09 4 FORM 4 0001567619-21-011941 9284
2021-05-13 4 FORM 4 0001567619-21-009897 9282
2021-05-10 10-Q 10-Q 0001564590-21-026023 001-38915 21906950 34 6971970 1
2021-05-10 8-K 8-K 2.02,9.01 0001564590-21-025718 001-38915 21905071 34 230984
2021-04-29 SC 13G/A sc13ga407422010_04292021.htm 0000921895-21-001171 005-91018 21871133 34 279112
2021-04-20 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-04-20 16:00:00 9999999995-21-001508 333-254606 21839480 33 1814
2021-04-19 DEF 14A DEF 14A 0001564590-21-019402 001-38915 21834607 34 1049829
2021-04-16 CORRESP filename1.htm 0001193125-21-118605 7308
2021-04-05 SC 13G/A SCHEDULE 13G/A 0001140361-21-011663 005-91018 21806778 34 87397
2021-03-25 UPLOAD filename1.pdf 0000000000-21-003616 40305
2021-03-23 S-8 S-8 0001564590-21-014848 333-254617 21764857 33 238687
2021-03-23 S-3 S-3 0001193125-21-090323 333-254606 21763131 33 630780
2021-03-23 10-K 10-K 0001564590-21-014676 001-38915 21763114 34 10296113 1
2021-03-23 8-K 8-K 2.02,9.01 0001564590-21-014671 001-38915 21763053 34 233599
2021-03-23 SEC STAFF LETTER filename1.pdf 9999999997-21-000602 277099
2021-02-26 4 FORM 4 0001567619-21-005115 5714
2021-02-26 4 FORM 4 0001567619-21-005114 5690
2021-02-26 4 FORM 4 0001567619-21-005113 5652
2021-02-26 4 FORM 4 0001567619-21-005112 5661
2021-02-26 4 FORM 4 0001567619-21-005111 5701
2021-02-23 SEC STAFF LETTER filename1.pdf 9999999997-21-000922 276146
2021-02-17 3 FORM 3 0001567619-21-004155 11555
2021-02-17 4 FORM 4 0001567619-21-004153 5592
2021-02-17 4 FORM 4 0001567619-21-004152 5592
2021-02-17 8-K 8-K 5.02,9.01 0001564590-21-006182 001-38915 21642541 34 54683
2021-02-16 SC 13G/A SC 13G/A 0001104659-21-023835 005-91018 21637680 34 152555
2021-02-16 SC 13G/A SC 13G/A 0001193125-21-044735 005-91018 21637320 34 63571
2021-02-11 SC 13G/A AMENDMENT NO. 3 TO THE SCHEDULE 13G 0000921895-21-000330 005-91018 21620764 34 279774
2021-02-10 4 FORM 4 0001567619-21-002869 9282
2021-02-10 4 FORM 4 0001567619-21-002852 20565
2021-02-04 4 OWNERSHIP DOCUMENT 0000921895-21-000223 26661
2021-01-28 4 FORM 4 0001567619-21-001669 15308
2021-01-22 SC 13G formsc13g.htm 0001493152-21-001613 005-91018 21544466 34 180962
2021-01-21 8-K 8-K 1.01,9.01 0001193125-21-013700 001-38915 21543012 34 251485
2021-01-21 424B5 424B5 0001193125-21-012713 333-238849 21540269 33 368847
2021-01-19 8-K 8-K 8.01 0001193125-21-010694 001-38915 21533733 34 16650
2021-01-11 8-K 8-K 7.01,9.01 0001564590-21-000736 001-38915 21519026 34 2965068
2020-12-23 4 FORM 4 0001567619-20-021549 7080
2020-12-22 4 FORM 4 0001567619-20-021499 7137
2020-12-15 4 FORM 4 0001567619-20-021089 4808
2020-12-15 SC 13D/A SC 13D/A 0001104659-20-135413 005-91018 201388054 34 251946
2020-12-08 4 FORM 4 0001567619-20-020759 7555
2020-11-16 SC 13D/A SC 13D/A 0001104659-20-125916 005-91018 201318273 34 249521
2020-11-13 4 4 0001104659-20-125231 21825
2020-11-12 10-Q 10-Q 0001564590-20-053546 001-38915 201306616 34 7827466 1
2020-11-12 8-K 8-K 2.02,9.01 0001564590-20-053198 001-38915 201302932 34 216470
2020-09-24 8-K 8-K 1.01,9.01 0001564590-20-044422 001-38915 201193447 34 46019
2020-09-16 8-K/A 8-K/A 5.02 0001564590-20-043709 001-38915 201178904 34 26075
2020-08-12 10-Q 10-Q 0001564590-20-039719 001-38915 201095951 34 8314704 1
2020-08-12 424B5 424B5 0001193125-20-217662 333-238849 201095611 33 545913
2020-08-12 8-K 8-K 2.02,9.01 0001564590-20-039459 001-38915 201093979 34 197801
2020-08-04 8-K 8-K 3.02,9.01 0001564590-20-035722 001-38915 201070818 34 46922
2020-07-02 4 OWNERSHIP DOCUMENT 0000921895-20-001915 26569
2020-07-02 4 FORM 4 0001567619-20-012887 5650
2020-06-30 4 FORM 4 0001567619-20-012700 5572
2020-06-30 3 FORM 3 0001567619-20-012699 10768
2020-06-30 8-K 8-K 5.02,9.01 0001564590-20-031138 001-38915 201000289 34 49077
2020-06-29 SC 13G SC 13G 0001193125-20-182578 005-91018 20998325 34 67380
2020-06-22 4 OWNERSHIP DOCUMENT 0000921895-20-001839 31310
2020-06-22 3 OWNERSHIP DOCUMENT 0000921895-20-001838 23800
2020-06-22 SC 13G/A AMENDMENT NO. 2 TO THE SCHEDULE 13G 0000921895-20-001826 005-91018 20979660 34 278912
2020-06-22 8-K 8-K 8.01,9.01 0001193125-20-175587 001-38915 20978975 34 235937
2020-06-19 4 FORM 4 0001567619-20-012462 11261
2020-06-19 3/A FORM 3/A 0001567619-20-012461 4776
2020-06-18 4 FORM 4 0001567619-20-012387 18604
2020-06-18 424B5 424B5 0001193125-20-172625 333-238849 20973493 33 588824
2020-06-18 4 FORM 4 0001567619-20-012377 5627
2020-06-18 4 FORM 4 0001567619-20-012376 5577

Latest XBRL company facts

One latest value per concept from companyfacts (231 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 96.69M 2026-10-31 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
dei EntityPublicFloat Entity Public Float USD 1.80B 2025-06-30 2025 FY 10-K 2026-02-17 0001193125-26-054533
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 1.05B 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001193125-26-191501
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 4.24M 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001193125-26-191501
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.72M 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001193125-26-191501
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 124.75 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001193125-26-191501
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 15.70M 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001193125-26-191501
ecd PeoTotalCompAmt PeoTotalCompAmt USD 9.51M 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001193125-26-191501
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 246.93 2025-01-01 2025-12-31 DEF 14A 2026-04-29 0001193125-26-191501
ffd NetFeeAmt NetFeeAmt USD 8,616.92 2026-11-03 S-8 2026-11-03 0001193125-26-445449
ffd NrrtvMaxAggtOfferingPric NrrtvMaxAggtOfferingPric USD 345.00M 2026-06-09 424B5 2026-06-09 0001193125-26-264032
ffd TtlFeeAmt TtlFeeAmt USD 8,616.92 2026-11-03 S-8 2026-11-03 0001193125-26-445449
ffd TtlOfferingAmt TtlOfferingAmt USD 99.05M 2026-11-03 S-8 2026-11-03 0001193125-26-445449
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-11-03 S-8 2026-11-03 0001193125-26-445449
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-06-09 424B5 2026-06-09 0001193125-26-264032
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 22.04M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 3.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 72.22M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 4.39M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 16.25M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -4.88M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 2.17B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 48.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 141.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 48.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 11.26M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-05 0000950170-25-102967
us-gaap Assets Assets USD 1.22B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap AssetsCurrent Assets, Current USD 871.97M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 4.89M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 989.38M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 984.50M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 671,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 261.45M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 109.40M 2019-09-30 2019 Q3 10-Q 2019-11-13 0001564590-19-043225
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 262.73M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 148.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0 2026-06-10 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 5.56M 2026-06-10 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 30.10M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 300.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 96.65M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 96.65M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap CommonStockValue Common Stock, Value, Issued USD 10,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -343.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ContractWithCustomerAssetNet Contract with Customer, Asset, after Allowance for Credit Loss USD 10.24M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ContractWithCustomerAssetNetCurrent Contract with Customer, Asset, after Allowance for Credit Loss, Current USD 10.24M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 2.17M 2025-09-30 2025 Q3 10-Q 2025-11-04 0001193125-25-264632
us-gaap ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized USD 19.46M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060206
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 490,000 2025-09-30 2025 Q3 10-Q 2025-11-04 0001193125-25-264632
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 1.68M 2025-09-30 2025 Q3 10-Q 2025-11-04 0001193125-25-264632
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 25.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ContractWithCustomerReceivableAfterAllowanceForCreditLoss Contract with Customer, Receivable, after Allowance for Credit Loss USD 0 2024-09-30 2024 Q3 10-Q 2024-11-04 0000950170-24-120675
us-gaap DeferredRentCredit Deferred Rent Credit USD 1.90M 2019-01-01 2019 FY 10-K 2020-03-24 0001564590-20-012501
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 299,000 2018-12-31 2019 FY 10-K 2020-03-24 0001564590-20-012501
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 1.57M 2018-12-31 2019 FY 10-K 2020-03-24 0001564590-20-012501
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 0 2023-12-31 2023 FY 10-K 2024-02-20 0000950170-24-017093
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 17.90M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 201.34M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 83.14M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 4.94M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 37.21M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 46.65M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 8.67M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 1.83M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 196.41M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 62,000 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 300,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006456
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.9 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006456
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 2.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 1.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap DividendsCommonStock Dividends, Common Stock USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-05 0001193125-26-206357
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 0 2018-12-30 2018-12-31 2019 FY 10-K 2020-03-24 0001564590-20-012501
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -3.56 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.36 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-10 0000950170-22-008946
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -3.56 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.262 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.195 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-24 0001564590-20-012501
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 1.77M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.016 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.015 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-18 0000950170-25-022183
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.125 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 12.73M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 148.50M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006456
us-gaap GainOnSaleOfInvestments Gain on Sale of Investments USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006456
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 68.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-20 0000950170-24-017093
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 29.77M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -23.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 60,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 275,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 14.22M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 4.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 31.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap IncreaseDecreaseInContractWithCustomerAsset Increase (Decrease) in Contract with Customer, Asset USD 4.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -587,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-05 0001193125-26-206357
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD -97,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-23 0001564590-21-014676
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 2.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 2.29M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-24 0001564590-20-012501
us-gaap InvestmentOwnedAtCost Investment Owned, at Cost USD 1.16B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap InvestmentsFairValueDisclosure Investments, Fair Value Disclosure USD 1.15B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 45.73M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 22.95M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 5.38M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 5.51M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 5.51M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 5.32M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 5.25M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.32M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 16.03M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap Liabilities Liabilities USD 123.96M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.22B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap LiabilitiesCurrent Liabilities, Current USD 96.41M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 577.09M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 312.29M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 364.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 41.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -256.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -336.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -10.78M 2019-10-01 2019-12-31 2019 FY 10-K 2020-03-24 0001564590-20-012501
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 31.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap OperatingExpenses Operating Expenses USD 394.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -368.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap OperatingLeaseCost Operating Lease, Cost USD 3.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 1.70M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006456
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 29.70M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 2.15M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 27.55M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap OperatingLeasePayments Operating Lease, Payments USD 700,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 21.64M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 1.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 9.70M 2018-12-31 2019 FY 10-K 2020-03-24 0001564590-20-012501
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 1.71M 2018-12-31 2019 FY 10-K 2020-03-24 0001564590-20-012501
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 1.69M 2018-12-31 2019 FY 10-K 2020-03-24 0001564590-20-012501
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 1.65M 2018-12-31 2019 FY 10-K 2020-03-24 0001564590-20-012501
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 1.60M 2018-12-31 2019 FY 10-K 2020-03-24 0001564590-20-012501
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 1.61M 2018-12-31 2019 FY 10-K 2020-03-24 0001564590-20-012501
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 1.44M 2018-12-31 2019 FY 10-K 2020-03-24 0001564590-20-012501
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 1.71M 2018-12-31 2019 Q3 10-Q 2019-11-13 0001564590-19-043225
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 1.40M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-24 0001564590-20-012501
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.115 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 650,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 909,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -57,000 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001564590-21-056989
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -7.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -7.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 18,000 2020-12-31 2021 FY 10-K 2022-03-18 0001564590-22-010922
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 12,000 2020-12-31 2021 FY 10-K 2022-03-18 0001564590-22-010922
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 8,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-24 0001564590-20-012501
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 94.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 71,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-23 0001564590-21-014676
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 419.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 374.38M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060206
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 2.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 23.18M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 50.32M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-24 0001564590-20-012501
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 182.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006456
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 105.36M 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-23 0001564590-21-014676
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 141.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 463.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-20 0000950170-24-017093
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 6.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 922,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -336.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 24.19M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 7.94M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 3,000 2024-12-31 2024 FY 10-K 2025-02-18 0000950170-25-022183
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 325.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap RestrictedCash Restricted Cash USD 1.28M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 1.28M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.07B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 25.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 139.79M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 48.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.705 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.597 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.051 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.037 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 2.50M 2023-12-31 2023 FY 10-K 2024-02-20 0000950170-24-017093
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 8.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 667,067 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-24 0001564590-20-012501
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 21.01 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 2.00M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-24 0001564590-20-012501
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 2.50M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-07 0000950170-23-060206
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 1.09B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.098 2019-05-21 2020 FY 10-K 2021-03-23 0001564590-21-014676
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 346,579 2016-01-01 2016-12-31 2019 FY 10-K 2020-03-24 0001564590-20-012501
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 138.39M 2019-01-01 2019-12-31 2021 FY 10-K 2022-03-18 0001564590-22-010922
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 922,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 182.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 6.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-07 0000950170-23-006456
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 0 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-12 0001564590-20-024653
us-gaap TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpense Tax Cuts and Jobs Act, Change in Tax Rate, Deferred Tax Asset, Income Tax Expense USD 2.30M 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-24 0001564590-20-012501
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 8.83M 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 185,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 2.74M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 169,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 31.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001193125-26-054533
us-gaap VariableLeaseCost Variable Lease, Cost USD 1.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 808,003 2022-07-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0000950170-22-023207
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 94.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 38.59M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-10 0000950170-22-008946
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 10,544 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-20 0000950170-24-017093
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 57.52M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-20 0000950170-24-017093
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 94.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001193125-26-445294

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →